India to Taiwan: Canagliflozin Export Trade Route

The India to Taiwan Canagliflozin corridor is one of India's established pharmaceutical export routes, with 29 shipments documented worth a combined $35.9K USD. The route is dominated by GMSANJIVANI LLP, which alone accounts for roughly 90% of all export value, reflecting the consolidated nature of India's canagliflozin manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with canagliflozin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 34.3%, placing it at rank #17 among India's top canagliflozin export destinations globally.

On the import side, key buyers of Indian canagliflozin in Taiwan include TO THE BUYER OF, MANAGER- GLOBAL INTERNATIONAL LOGISTICS LIMITED, TO THE MANAGER- and 4 others. TO THE BUYER OF is the single largest importer with 8 shipments valued at $13.1K USD.

India's canagliflozin exports to Taiwan are driven primarily by a handful of large-scale manufacturers. GMSANJIVANI LLP with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Taiwan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GMSANJIVANI LLP, GMSANJIVANI LLP — together account for 100% of total trade value on this route. The average shipment value of $1.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as contain medicines harmless pharmaceutical products - details as per attached export annexure invoice no - canagliflozin? and contain medicines harmless pharmaceutical products - details as per attached export annexure invoice no - canagliflozin, suggesting that buyers in Taiwan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE BUYER OF is the largest importer with 8 shipments worth $13.1K USD — representing 37% of all canagliflozin imports from India on this route. A total of 7 buyers are active on this corridor.